首页> 外文期刊>International journal of oncology >Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer
【24h】

Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer

机译:实时定量RT-PCR检测大肠癌患者外周血和引流血中分离出的肿瘤细胞的价值及临床意义

获取原文
           

摘要

The clinical significance of isolated tumor cells (ITC) circulating in the blood of patients with colorectal cancer is unclear. In this study, we investigated the relationship between the presence of ITC that express carcinoembryonic antigen (CEA) and/or cytokeratin 20 (CK20) transcripts in the blood and the clinicopathological findings and prognosis using the quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) assay. We studied peripheral blood and tumor drainage blood from 167 patients with colorectal cancer. Quantitative real-time RT-PCR assay was able to detect one tumor cell in 3x106 peripheral blood mononuclear cells. Applying a cut-off value, CEA and/or CK20 (CEA/CK20) were detected in 10.2% (17/167) of the patients' preoperative peripheral blood samples and 34.1% (57/167) of the patients' tumor drainage blood samples. In the relationship between the CEA/CK20 of the blood and the clinicopathological factors, a significant correlation was demonstrated between the positivity of marker genes and the depth of invasion, venous invasion, lymph node metastasis, liver metastasis or stage. The disease-free and overall survival of patients with CEA/CK20-positive peripheral or tumor drainage blood was significantly shorter than that of marker gene-negative patients. CEA/CK20 transcripts in tumor drainage blood were independent factors for prognosis in disease-free survival and overall survival. These results suggest that detecting CEA/CK20 mRNA in tumor drainage blood by real-time RT-PCR has prognostic value in patients with colorectal cancer. Large scale and long-term clinical studies are needed to confirm the prognostic value of genetically detecting ITC in the peripheral blood.
机译:大肠癌患者血液中循环的孤立肿瘤细胞(ITC)的临床意义尚不清楚。在这项研究中,我们使用实时定量逆转录聚合酶链反应研究了血液中表达癌胚抗原(CEA)和/或细胞角蛋白20(CK20)转录本的ITC与临床病理发现和预后之间的关系。 (RT-PCR)分析。我们研究了167例结直肠癌患者的外周血和肿瘤引流血。实时定量RT-PCR分析能够检测3x106个外周血单个核细胞中的一个肿瘤细胞。应用临界值,在患者术前外周血样本的10.2%(17/167)和患者肿瘤引流血的34.1%(57/167)中检测到CEA和/或CK20(CEA / CK20)样品。在血液中CEA / CK20与临床病理因素之间的关系中,证明了标记基因的阳性与浸润深度,静脉浸润,淋巴结转移,肝转移或阶段之间存在显着相关性。 CEA / CK20阳性外周血或肿瘤引流血患者的无病生存期和总生存期明显短于标记基因阴性患者。肿瘤引流血中的CEA / CK20转录本是无病生存期和总生存期的独立因素。这些结果表明通过实时RT-PCR检测肿瘤引流血中的CEA / CK20 mRNA对大肠癌患者具有预后价值。需要大规模和长期的临床研究来证实基因检测外周血中ITC的预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号